CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 337

Industry reads hand-picked by our editors

Jan 15, 2016

Reuters
U.S. patent office rules against Amgen Humira challenge
WSJ
FDA Took 17 Months to Notify Doctors on Scopes’ ‘Superbug’ Dangers
Healthcare Dive
10 negotiating tactics to stay in the M&A game
Reuters
Sierra Leone Ebola sample was in tests as WHO declared epidemic over

Jan 14, 2016

Reuters
FDA rejects BioMarin's DMD drug
Bloomberg
Pfizer Said to Weigh Sale of Pump Unit Acquired in Hospira Deal
Bloomberg
At Biotech Party, Gender Diversity Means Cocktail Waitresses
Stat
FDA faulted for failure to track safety issues with drugs already on market

Jan 13, 2016

Fortune
Biosimilars Are Coming After Big Pharma's Bottom Line
Wall Street Journal
A Day in the Life of Anne Wojcicki
The Economic Times
Strides Shasun gets CCI nod to buy Sun Pharma's two divisions

Jan 12, 2016

Bloomberg
Celgene Names Alles as CEO; Hugin to Be Executive Chairman
Reuters
U.S. copy of GSK's Advair a step closer as Mylan files generic version
Stat
Drug makers dismiss outrage over high prices as ‘abomination’

Jan 11, 2016

Boston Globe
Drug price policies, China may slow biotech bull market
Wall Street Journal
Drugmakers Raise Prices Despite Criticisms
Reuters
No quick fix seen for Novartis's troubled Alcon unit
Stat
Startup backed by big names aims to detect early cancer in blood

Jan 08, 2016

Reuters
Roche says encouraged by cancer drug atezolizumab study
Wall Street Journal
Walgreens Boots Defends Valeant Deal and Might Look to Make More
PharmaTimes
Sanofi/Regeneron's new rheumatoid arthritis biologic gets US review

Jan 07, 2016

Stat
New company seeks to leverage cellular cleanup crew to halt disease
Reuters
Blood plasma from Ebola survivors fails to prevent deaths in field study
Vox
The hidden drugs in your favorite supplements
Fierce Biotech
Dynavax shares shoot up as hep B PhIII vaccine blasts by rival GSK

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Industry Report
CGT Commercialization: Tackling Barriers to Market Success Custom content for Cencora
Playbook
Centralized Clinical Trial Recruitment: A Strategic Plan Custom content for WCG
Trendline
Inside the growing treatment market for rare diseases Supported by Advanced Clinical

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Understanding Publication Impact and Engagement with Data and AI-Driven Solutions Webinar - on demand • Provided by Altmetric
Trends and Innovations in Life Science Qualitative Research Webinar - on demand • Provided by Konovo

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.